Asensus Surgical Inc (ASXC)
0.4197
+0.01 (+2.02%)
USD |
NYAM |
May 19, 15:55
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 99.24M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -79.53% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 13.65 |
| Price to Book Value | 0.6580 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 99.68% |
News
Headline
Wire
Time (ET)
Yahoo
05/11 06:55
MT Newswires
05/04 16:35
MT Newswires
05/04 16:35
Yahoo
05/04 16:05
Yahoo
04/27 06:55
MT Newswires
02/28 16:22
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 08/05/2022* | -- | Results | Q2 2022 | -- | -0.08 | -- | |
| 08/05/2022* | 16:30 EST | Earnings Call | Q2 2022 | -- | -- | -- | |
| 05/04/2022 | -- | Results | Q1 2022 | -0.07 | -0.08 | 12.50% | |
| 05/04/2022 | 16:30 EST | Earnings Call | Q1 2022 | -- | -- | -- | |
| 02/28/2022 | -- | Results | Q4 2021 | -0.08 | -0.07 | -12.29% | |
| 02/28/2022 | 16:30 EST | Earnings Call | Q4 2021 | -- | -- | -- | |
| 11/03/2021 | -- | Results | Q3 2021 | -0.07 | -0.06 | -16.67% | |
| 11/03/2021 | 16:30 EST | Earnings Call | Q3 2021 | -- | -- | -- |
*Estimated Date/Time
Earnings
Profile
Edit
| Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. Its single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery. |
| URL | https://www.asensus.com |
| Investor Relations URL | https://ir.asensus.com |
| HQ State/Province | North Carolina |
| Sector | Healthcare |
| Industry | Medical Devices |
| Equity Style | Small Cap/Value |
| Next Earnings Release | Aug. 05, 2022 (est.) |
| Last Earnings Release | May. 04, 2022 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | -- |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 0.00 |
| Yield to Sector | 0.00 |
| Yield to Industry | 0.00 |
| Last Dividend Amt. | -- |
| Dividend Frequency | -- |
| Last Ex-Dividend Date | -- |
| Yield (TTM) | 0% |
| Forward Yield | -- |
| Payout Ratio | 0.00% |
| Cash Payout Ratio | 0.00% |
| Consistent Payer (5Y) | No |
| Consistent Growth (5Y) | No |
Risk Info
Total Returns Comparison
Annual Total Returns Versus Peers
As of May 18, 2022.
Fundamentals
| Revenue (TTM) | 7.215M |
| Total Expenses (TTM) | 77.35M |
| Net Income (TTM) | -64.25M |
| Total Assets (Quarterly) | 166.56M |
| Total Liabilities (Quarterly) | 15.74M |
| Shareholders Equity (Quarterly) | 150.82M |
| Cash from Operations (TTM) | -46.36M |
| Cash from Investing (TTM) | -96.23M |
| Cash from Financing (TTM) | 1.764M |
Ratings
Profile
Edit
| Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. Its single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery. |
| URL | https://www.asensus.com |
| Investor Relations URL | https://ir.asensus.com |
| HQ State/Province | North Carolina |
| Sector | Healthcare |
| Industry | Medical Devices |
| Equity Style | Small Cap/Value |
| Next Earnings Release | Aug. 05, 2022 (est.) |
| Last Earnings Release | May. 04, 2022 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Risk Info
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Other Resources
| Whale Wisdom | 13F Filings |
| Seeking Alpha | Call Transcripts |
| Morningstar | Insider Trading |
| Nasdaq | Institutional Ownership |
| Nasdaq | Option Chain |
| SEC | SEC Filings |
| ASXC Tweets |